These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28951797)

  • 1. Earlier Intervention with Deep Brain Stimulation for Parkinson's Disease.
    Suarez-Cedeno G; Suescun J; Schiess MC
    Parkinsons Dis; 2017; 2017():9358153. PubMed ID: 28951797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled study.
    Vitek JL; Jain R; Chen L; Tröster AI; Schrock LE; House PA; Giroux ML; Hebb AO; Farris SM; Whiting DM; Leichliter TA; Ostrem JL; San Luciano M; Galifianakis N; Verhagen Metman L; Sani S; Karl JA; Siddiqui MS; Tatter SB; Ul Haq I; Machado AG; Gostkowski M; Tagliati M; Mamelak AN; Okun MS; Foote KD; Moguel-Cobos G; Ponce FA; Pahwa R; Nazzaro JM; Buetefisch CM; Gross RE; Luca CC; Jagid JR; Revuelta GJ; Takacs I; Pourfar MH; Mogilner AY; Duker AP; Mandybur GT; Rosenow JM; Cooper SE; Park MC; Khandhar SM; Sedrak M; Phibbs FT; Pilitsis JG; Uitti RJ; Starr PA
    Lancet Neurol; 2020 Jun; 19(6):491-501. PubMed ID: 32470421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians.
    Cabrera LY; Sarva H; Sidiropoulos C
    World Neurosurg; 2019 Aug; 128():e16-e20. PubMed ID: 30880198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep brain stimulation for Parkinson's disease: meta-analysis of results of randomized trials at varying lengths of follow-up.
    Mansouri A; Taslimi S; Badhiwala JH; Witiw CD; Nassiri F; Odekerken VJJ; De Bie RMA; Kalia SK; Hodaie M; Munhoz RP; Fasano A; Lozano AM
    J Neurosurg; 2018 Apr; 128(4):1199-1213. PubMed ID: 28665252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspective: Phase Amplitude Coupling-Based Phase-Dependent Neuromodulation in Parkinson's Disease.
    Hwang BY; Salimpour Y; Tsehay YK; Anderson WS; Mills KA
    Front Neurosci; 2020; 14():558967. PubMed ID: 33132822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-dopa Deep Brain Stimulation: Is Early Deep Brain Stimulation Able to Modify the Natural Course of Parkinson's Disease?
    Porta M; Servello D; Zekaj E; Gonzalez-Escamilla G; Groppa S
    Front Neurosci; 2020; 14():492. PubMed ID: 32581675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial.
    Okun MS; Gallo BV; Mandybur G; Jagid J; Foote KD; Revilla FJ; Alterman R; Jankovic J; Simpson R; Junn F; Verhagen L; Arle JE; Ford B; Goodman RR; Stewart RM; Horn S; Baltuch GH; Kopell BH; Marshall F; Peichel D; Pahwa R; Lyons KE; Tröster AI; Vitek JL; Tagliati M;
    Lancet Neurol; 2012 Feb; 11(2):140-9. PubMed ID: 22239915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease.
    Hacker ML; Tonascia J; Turchan M; Currie A; Heusinkveld L; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Wang L; Shi Y; Shade DM; Sternberg AL; Drye LT; Charles D
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1177-83. PubMed ID: 26306000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative historical and demographic study of the neuromodulation management techniques of deep brain stimulation for dystonia and cochlear implantation for sensorineural deafness in children.
    Hudson VE; Elniel A; Ughratdar I; Zebian B; Selway R; Lin JP
    Eur J Paediatr Neurol; 2017 Jan; 21(1):122-135. PubMed ID: 27562095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical appraisal of the recent US FDA approval for earlier DBS intervention.
    Cabrera LY; Goudreau J; Sidiropoulos C
    Neurology; 2018 Jul; 91(3):133-136. PubMed ID: 29898975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral nerve grafts implanted into the substantia nigra in patients with Parkinson's disease during deep brain stimulation surgery: 1-year follow-up study of safety, feasibility, and clinical outcome.
    van Horne CG; Quintero JE; Slevin JT; Anderson-Mooney A; Gurwell JA; Welleford AS; Lamm JR; Wagner RP; Gerhardt GA
    J Neurosurg; 2018 Dec; 129(6):1550-1561. PubMed ID: 29451447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials.
    Tan ZG; Zhou Q; Huang T; Jiang Y
    Clin Interv Aging; 2016; 11():777-86. PubMed ID: 27382262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep brain stimulation for the treatment of Parkinson's disease.
    Volkmann J
    J Clin Neurophysiol; 2004; 21(1):6-17. PubMed ID: 15097290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-source current steering in subthalamic nucleus deep brain stimulation for Parkinson's disease (the VANTAGE study): a non-randomised, prospective, multicentre, open-label study.
    Timmermann L; Jain R; Chen L; Maarouf M; Barbe MT; Allert N; Brücke T; Kaiser I; Beirer S; Sejio F; Suarez E; Lozano B; Haegelen C; Vérin M; Porta M; Servello D; Gill S; Whone A; Van Dyck N; Alesch F
    Lancet Neurol; 2015 Jul; 14(7):693-701. PubMed ID: 26027940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early deep brain stimulation for Parkinson's disease].
    Schnitzler A; Fuchs G; Baas H; Dillmann U; Hilker R; Oechsner M
    Fortschr Neurol Psychiatr; 2010 Mar; 78 Suppl 1():S37-40. PubMed ID: 20195941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative symptoms of psychosis after deep brain stimulation in patients with Parkinson's disease.
    Qureshi AA; Cheng JJ; Sunshine AN; Wu A; Pontone GM; Cascella N; Lenz FA; Grill SE; Anderson WS
    Neurosurg Focus; 2015 Jun; 38(6):E5. PubMed ID: 26030705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthalamic Nucleus Deep Brain Stimulation May Reduce Medication Costs in Early Stage Parkinson's Disease.
    Hacker ML; Currie AD; Molinari AL; Turchan M; Millan SM; Heusinkveld LE; Roach J; Konrad PE; Davis TL; Neimat JS; Phibbs FT; Hedera P; Byrne DW; Charles D
    J Parkinsons Dis; 2016; 6(1):125-31. PubMed ID: 26967937
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.